TRANSCRIPT

Q1 2022 — Earnings call remarks

Q1 2022PDF · 8 pages157 KB
Earnings Conference Call
First Quarter 2022 Remarks
April 14, 2022
Moderator:
Good morning, and welcome to the UnitedHealth Group First Quarter 2022 Earnings
Conference Call. A question and answer session will follow UnitedHealth Group’s prepared
remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements
under U.S. federal securities laws. These statements are subject to risks and uncertainties that
could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with
the Securities and Exchange Commission, including the cautionary statements included in our
current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP
amounts is available on the “Financial & Earnings Reports” section of the Company’s Investor
Relations page at www.unitedhealthgroup.com.
Information presented on this call is contained in the Earnings Release we issued this morning
and in our Form 8-K dated April 14, 2022, which may be accessed from the Investor Relations
page of the Company’s website. I will now turn the conference over to the chief executive officer
of UnitedHealth Group, Andrew Witty.
Andrew Witty
Good morning and thank you all for joining us today.
Coming into this quarter, we set clear objectives for the year:
• to drive strong execution of our long-term strategy and deliver high-quality,
diversified growth;
• pursue excellence in every consumer experience and at every touch point; and
• apply technology to help all stakeholders to improve access, affordability,
outcomes and experiences.

-- 1 of 8 --

2
As our results show, we are delivering on these objectives, so I would like to start this
morning’s call by thanking my colleagues — the 350,000 people of Optum and
UnitedHealthcare. Their dedicated work gives us the confidence today to increase our
2022 adjusted earnings per share outlook to a range of $21.20 to $21.70 per share.
At our November Investor Conference, we described five key areas to drive our long-
term 13% to 16% earnings per share growth rate.
In the first area — value-based care delivery — Optum Health continued its robust
momentum into the first quarter, characterized by its integrated approach and high
clinical quality. After a strong start to the year, we now expect to add 600,000 patients
under value-based arrangements during 2022, compared to our initial estimate of
500,000.
Our approach focuses on providing quality care in the setting that makes most sense for
the patients we serve. Our pending combination with LHC Group will reinforce our ability
to deliver care and support in the home, as well as in other ambulatory locations.
Within the second growth area, health benefits — we are rapidly advancing the quality,
innovation and consumer appeal of our plan offerings and bringing value-based care to
scale.
In Medicare Advantage, our strategic balance of benefit stability and enhancements
once again helped to deliver strong growth. We remain well on track to serve an
additional 800,000 people in 2022, consistent with the expectations we set last
November.
In the commercial benefits market, our innovative offerings such as physician-led and
virtual-first plans have grown to serve 350,000 more people over the past year. This
underscores the consumer appeal for these high-quality, primary care-based coverage
options. Nearly 90% of newly enrolled people in our individual exchange offerings
selected plans with significant virtual components in the most recent open enrollment
period, and nearly 30% selected a virtual-first offering. You will see us expand such
offerings as we look forward to 2023.
In our third growth area, health technology, we continue to execute on the major new
health system partnerships initiated last year, including a broad relationship with SSM
Health and its 11,000 providers caring for people throughout the Midwest.

-- 2 of 8 --

3
We are helping our health system partners alleviate administrative burdens and creating
operational capacity for these organizations to focus on delivering high-quality patient
care and experiences. These partnerships move far beyond traditional revenue cycle
management, with both clinical and technology features becoming important.
Fourth: our developing efforts in health financial services … streamlining and simplifying
payments for providers, payers, and consumers … while reducing friction and
increasing speed and convenience.
Consider our new integrated consumer card, which we introduced in January. Many
people typically have separate cards for clinical care, pharmacy benefits, food
assistance programs, fitness, rewards programs and more. We’ve combined these
benefits into a single card, vastly simplifying the experience for consumers and
providers … and we plan to do even more in the future.
And finally, Pharmacy Services. The high cost of specialty drugs is one of the most
pressing issues for our health plan partners. Drawing upon all of Optum’s advanced
analytical capabilities, we are collaborating with health plans to provide clinicians
access to real-time medical and pharmacy analytics — which are coordinated with a
patient’s specific benefit plan design — enabling clinicians to determine the most
effective and appropriate therapies at the point of care. Our initial results are highly
positive, helping to lower specialty costs by over 15%. Overall, Optum Rx’s performance
in the quarter, healthy retention rates and strong sales pipeline provide a great
foundation for growth.
These efforts — from expanding in-home and broad value-based care offerings … to
enhancements to Medicare Advantage … to simplifying how to finance care — are
designed to create greater value for consumers and, more broadly, have a profound
impact on the lives of families and individuals in communities with all levels of need
across America — which is a powerful motivation for all of us at this company each and
every day.
Dirk McMahon, our president and chief operating officer, will now share more about
these efforts.
Dirk?

-- 3 of 8 --

4
Dirk McMahon
Thank you, Andrew.
There is no more important aspect of the consumer experience in health care than
convenient access to quality care. Not theoretical access; but care, when and where
people need it.
Testing, for instance, is an area where we see significant opportunity to improve the
consumer experience. It can be a burden for people to test for conditions such as
colorectal cancer. As a result, too often, people just won’t deal with the hassle, and as a
result, early-stage conditions go undiagnosed, and people don’t get the care they need
until things get really serious — which is bad for their health and results in unnecessarily
higher intensity treatments and costs in the future.
Like so many of you, we have observed more willingness by patients for trial and
adoption of in-home testing for many types of common conditions. However, it can be
challenging for people to first find tests and then make sure the results get back into a
doctor’s workflow. Patients need to call providers for a prescription, go to disparate
locations to pick up the test and then, somehow, get the piece of paper with a test result
into an already busy clinic operation.
At UnitedHealthcare, we’ve introduced an integrated solution that addresses all of the
tasks that need to occur sequentially for a test result to get into a clinic’s system. This
digitally enabled solution is resulting in a nearly 10% increase in people obtaining
necessary screening versus a multistep process. We are expanding this vital capability
to more people and making additional types of tests available as well.
As many of you know, the first quarter tends to be the most impactful in setting us up for
operational success for the remainder of the year. The ease of that initial experience for
people has a lasting impact on consumer and customer perceptions and buying
decisions … not just for the next three months, but often for years to come.
So, I thought it would be timely and helpful to provide a bit of a performance report card
for the quarter. The short version: This is where we owe a great thank you to the people
of Optum and UnitedHealthcare.
Perhaps nowhere was this more apparent than in the onboarding of the many new
people served under value-based arrangements within Optum Health. Investing in the
preparation of systems and training of physicians and staff was critical in laying the

-- 4 of 8 --

5
groundwork to provide high-quality care for these new patients and expanding into new
geographies.
For example, in Ohio and New York we are observing early improvements in post-acute
trends — such as skilled-nursing facility admits declining 25% in just the first quarter of
operation. It’s a testament to the deep integration of our post-acute capabilities for
transitioning patients to the most appropriate setting for their needs, as well as a
patient-centric orientation of our local care delivery organizations and their vigilance on
care continuity.
At UnitedHealthcare, our digital investments are continuing to serve our care providers
and helping advance our efforts to move toward a paperless consumer experience. In
the first quarter, visits to our digital portal continued to increase while provider support
calls declined about 12% from our historical averages. Importantly, we have driven a
38% increase in providers using digital documents instead of paper in this quarter
compared to last year. We expect the efforts we have taken in just this quarter will save
80 tons of paper over the next five years.
Before handing off to John, let me turn briefly to our pending combination with Change
Healthcare. By now it should be clear we are deeply committed to helping achieve a
simpler, more intelligent and adaptive health system for patients, payers and providers.
The combination of Optum and Change Healthcare will connect and simplify core
clinical, administrative and payment processes health care providers and payers
depend on to serve patients. Increasing efficiency and reducing friction will benefit the
entire health system, resulting in lower costs and a better experience for all
stakeholders. Our extended agreement with Change Healthcare reflects our firm belief
in the potential benefits of this combination to improve health care, and in our ability to
successfully overcome the challenge to this merger.
With that, now I’ll turn it over to Chief Financial Officer John Rex.
John Rex
Thank you, Dirk, and good morning everyone.
Our first quarter 2022 performance positions us well to deliver on our full year financial
and growth objectives.
Revenues grew by $10 billion or 14% to $80 billion over the year ago first quarter, with
double-digit growth at both Optum and UnitedHealthcare. This strong, diversified growth

-- 5 of 8 --

6
was largely organic, with balanced contributions from across both our services and
benefits operating platforms.
Compared to a year-ago, we are:
• adding over 1 million more people to Optum Health;
• supporting 30% more patients in value-based relationships;
• providing over 20 million more prescriptions, and
• serving 1.5 million more people across our health benefit offerings.
I’ll start by providing a little color on care patterns over the course of the quarter and
then turn to our individual businesses.
As you’d expect, there was considerable variation in care patterns due to the COVID
incidence peak early in the quarter. For example, in January, we had about 40,000
COVID-related hospitalizations, the highest of any month since the onset of the
pandemic. By March, these had declined to around 2,000.
Overall, care in the quarter was about at baseline levels though we observe pockets
that are modestly below historical baseline, such as emergency department and
pediatric visits. However, we are not assuming this is a permanent shift in consumer
behavior.
As it relates to potential longer-term health impacts on people due to care which was
deferred during the height of the pandemic, thus far we are not seeing the increasing
acuity that many expected. For example, initial oncology-related diagnosis levels are
consistent with historical averages. Of course, our core focus remains on getting people
the care they need, and we are encouraged that critical screenings are occurring at
normalized levels.
Moving now to business performance:
Optum Health revenue grew 34% in the first quarter and earnings from operations rose
over 40%. Revenue per consumer grew 33%. This was driven primarily by the
increasing number of patients served under value-based arrangements. Continued
augmentation of our value-based care offerings, such as expanding digital care and our
services into the home, give us the opportunity to serve more people, much more
broadly and deeply — and we expect to grow strongly — for years to come.

-- 6 of 8 --

7
Optum Insight revenue grew 13% year over year. The revenue backlog was
$22.8 billion, growth of $2 billion or 10% over the prior year. Our expanding health
system partnerships are contributing to this growth. And we expect the number and
breadth of these partnerships to continue to grow.
Optum Rx revenues grew 11% to $24 billion, reflecting the strength of new business
relationships secured over the course of last year. We typically incur significant
investments in the early months of these expansions to assure strong performance and
value for our customers.
Turning to UnitedHealthcare, revenue growth of 14% was driven across the businesses.
Our Medicare Advantage offerings remain on track to add up to 800,000 people. About
three quarters will be in Individual and Group Medicare Advantage and the remainder in
Dual Special Needs Plans. New seniors aging into Medicare are increasingly selecting
Medicare Advantage based on the value it offers. And the Five Star quality plan
performance we achieved this year enables us to enroll people in our plan offerings
throughout the year.
People served by our Medicaid offerings grew by over 150,000 in the first quarter, and
is now approaching 8 million. Our growth outlook for the remainder of the year
continues to incorporate an expectation that states will resume eligibility
redeterminations when the public health emergency lapses, resulting in modest net
attrition.
First quarter commercial enrollment was in line with our expectations. The decline in
people served under fee-based arrangements was driven by three previously known
customer transitions, which were offset by core growth.
We see the number of people served overall increasing as we progress through ’22,
driven by the strong market response to our more recently introduced innovative
offerings, as well as the continued recovery in the total number of people covered by
employer health benefits, which typically lags reported job growth.
Our capital capacities remain strong. First quarter cash flows from operations of
$5.3 billion, or 1 times net income, were consistent with our expectations. And we
continue to expect full year cash flows of about $24 billion, or 1.2 times net income.
We returned nearly $4 billion to shareholders in the quarter through dividends and share
repurchases and ended the quarter with a debt to capital ratio of 38%. And as we look

-- 7 of 8 --

8
toward completing both the LHC and Change combinations this year, we will continue to
have ample capacities to expand upon the ways we can serve people and help them to
live healthier lives.
As noted earlier, based on this growth outlook, today we increased our adjusted
earnings outlook to a range of $21.20 to $21.70 per share. And we continue to expect
the seasonal pattern to be more consistent with our historical experience, with just
under 50% of the full year earnings in the first half.
Now I’ll turn it back to Andrew.
Andrew Witty
Thank you, John.
I hope that you will recognize the consistent themes that we laid out last year as our
guideposts for sustainable growth. Our focus on execution and continuous improvement
across our businesses is a characteristic that we will sustain as we build upon this
strong start to 2022.

-- 8 of 8 --